GlassScriptPhysician profile
Mitchell S Kramer
NPI 1821102971
$5,546.54
in general payments reported to CMS, 2019-2025
17 companies · $715 in 2025
The $715 reported for 2025 was more than what 88% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $34.46 · 2021: $13.02 · 2022: $45.85 · 2023: $355 · 2024: $4,045 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,500 · Food and Beverage: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,500.00 |
| Food and Beverage | $1,615.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guard Medical INC. | $3,879.56 | 2023-2024 | Npseal Large, Npseal Medium, Npseal (5) |
| Hologic Sales and Service, LLC | $545.77 | 2019-2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Amgen INC. | $350.96 | 2019-2025 | Evenity |
| Organon LLC | $153.67 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $114.84 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Sumitomo Pharma America, INC. | $99.55 | 2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $74.84 | 2025 | Veozah |
| Mayne Pharma Commercial LLC | $65.86 | 2022-2025 | |
| Abbvie INC. | $45.21 | 2019-2021 | |
| Ethicon US, LLC | $43.43 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal, Surgicel Nu-Knit |
| Bayer Healthcare Pharmaceuticals INC. | $42.20 | 2020-2025 | |
| Evofem Biosciences, INC. | $26.95 | 2025 | Phexxi, Solosec, Phexx |
| Meditrina | $24.89 | 2024 | |
| Smith+Nephew, INC. | $23.18 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Biogen, INC. | $22.16 | 2025 | Zurzuvae |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $17.78 | 2019 | |
| Pfizer INC. | $15.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.